Starpharma Holdings reported AUD11.7M in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Medical Developments International AUD 21.61M 11.59M Dec/2025
Mesoblast USD 82.31M 26.16M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025